indianclinicaltrials

AML

A Phase 4 Study of Venetoclax in Combination with Azacitidine in Indian Subjects with Newly Diagnosed Acute Myeloid Leukemia Who are Ineligible for Standard Induction Therapy RGCI, DELHI

Scroll to Top